Form 10-Q IRIDEX CORP For: Jun 29
IRIDEX Corporation (IRIX)
Last iridex corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
IRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRIX alerts
High impacting IRIDEX Corporation news events
Weekly update
A roundup of the hottest topics
IRIX
News
- IRIDEX Co. (<a href="https://www.marketbeat.com/stocks/NASDAQ/IRIX/price-target/">NASDAQ: IRIX</a>) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- IRIDEX Co. (<a href="https://www.marketbeat.com/stocks/NASDAQ/IRIX/price-target/">NASDAQ: IRIX</a>) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Iridex's Cyclo G6 platform for treating glaucoma gets regulatory clearance in China [Seeking Alpha]Seeking Alpha
- Iridex Obtains Regulatory Clearance For Cyclo G6® Glaucoma Platform In China [TheStreet.com]TheStreet.com
- Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in ChinaGlobeNewswire
IRIX
Earnings
- 5/12/22 - Beat
IRIX
Sec Filings
- 6/16/22 - Form 4
- 6/16/22 - Form 4
- 6/16/22 - Form 4
- IRIX's page on the SEC website